Treasurer of the State of North Carolina’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$921K Buy
42,340
+3,486
+9% +$67.5K ﹤0.01% 948
2025
Q4
$836K Sell
38,854
-2,837
-7% -$59.8K ﹤0.01% 967
2025
Q3
$803K Sell
41,691
-1,630
-4% -$29.1K ﹤0.01% 983
2025
Q2
$741K Buy
43,321
+1,433
+3% +$61.1K ﹤0.01% 996
2025
Q1
$2.67M Sell
41,888
-19,470
-32% -$2.05M 0.01% 796
2024
Q4
$7.46M Sell
61,358
-1,000
-2% -$123K 0.03% 486
2024
Q3
$7.79M Buy
62,358
+860
+1% +$119K 0.03% 482
2024
Q2
$9.72M Sell
61,498
-809
-1% -$104K 0.04% 390
2024
Q1
$8.07M Buy
62,307
+22,630
+57% +$2.77M 0.04% 446
2023
Q4
$3.83M Sell
39,677
-22,235
-36% -$2.13M 0.02% 648
2023
Q3
$7.5M Sell
61,912
-750
-1% -$84.8K 0.04% 414
2023
Q2
$7.18M Buy
62,662
+2,355
+4% +$304K 0.04% 438
2023
Q1
$8.31M Sell
60,307
-270
-0.4% -$35K 0.05% 385
2022
Q4
$7.85M Buy
60,577
+10,430
+21% +$1.21M 0.05% 394
2022
Q3
$5.54M Buy
50,147
+14,550
+41% +$1.47M 0.04% 451
2022
Q2
$2.67M Buy
35,597
+4,914
+16% +$362K 0.02% 704
2022
Q1
$2.4M Buy
30,683
+485
+2% +$37.1K 0.01% 750
2021
Q4
$2.72M Buy
30,198
+2,710
+10% +$232K 0.01% 720
2021
Q3
$2.54M Buy
27,488
+929
+3% +$71.6K 0.01% 735
2021
Q2
$2.06M Sell
26,559
-1,070
-4% -$81.1K 0.01% 821
2021
Q1
$2.06M Sell
27,629
-22,151
-44% -$2.04M 0.01% 780
2020
Q4
$8.49M Sell
49,780
-210
-0.4% -$31.1K 0.06% 320
2020
Q3
$7.02M Sell
49,990
-350
-0.7% -$53.2K 0.05% 323
2020
Q2
$8.07M Buy
50,340
+12,540
+33% +$1.71M 0.07% 273
2020
Q1
$3.7M Buy
37,800
+12,200
+48% +$1.39M 0.03% 438
2019
Q4
$3.3M Buy
25,600
+1,790
+8% +$181K 0.03% 425
2019
Q3
$1.79M Sell
23,810
-5,610
-19% -$663K 0.02% 604
2019
Q2
$4.47M Sell
29,420
-4,290
-13% -$521K 0.03% 510
2019
Q1
$4.02M Sell
33,710
-2,159
-6% -$278K 0.03% 526
2018
Q4
$3.91M Buy
35,869
+1,645
+5% +$206K 0.03% 491
2018
Q3
$5.53M Buy
34,224
+20,288
+146% +$2.77M 0.03% 433
2018
Q2
$1.84M Buy
+13,936
New +$1.31M 0.02% 617

Other funds holding SRPT